维普中文期刊产品整合服务
230篇 您的检索式:作者名="Caterson"
    题名 作者 年代 出处 被引量
1Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect显示文摘Objective: To identify the relationship between T-2 toxin and Kashin-Beck disease (KBD),the effects of T-2 toxin on aggrecan metabolism in human chondrocytes and cartilage were investigated in vitro. Methods: Chondrocytes were isolated from human articular cartilage and cultured in vitro. Hyaluronic acid (HA),soluble CD44 (sCD44),IL-1β and TNF-α levels in super-natants were measured by enzyme-linked immunosorbent assay (ELISA). CD44 content in chondrocyte membrane was deter-mined by flow cytometry (FCM). CD44,hyaluronic acid synthetase-2 (HAS-2) and aggrecanases mRNA levels in chondrocytes were determined using reverse transcription polymerase chain reaction (RT-PCR). Immunocytochemical method was used to investigate expressions of BC-13,3-B-3(-) and 2-B-6 epitopes in the cartilage reconstructed in vitro. Results: T-2 toxin inhibited CD44,HAS-2,and aggrecan mRNA expressions,but promoted aggrecanase-2 mRNA expression. Meanwhile,CD44 expression was found to be the lowest in the chondrocytes cultured with T-2 toxin and the highest in control plus selenium group. In addition,ELISA results indicated that there were higher sCD44,IL-1β and TNF-α levels in T-2 toxin group. Similarly,higher HA levels were also observed in T-2 toxin group using radioimmunoprecipitation assay (RIPA). Furthermore,using monoclonal antibodies BC-13,3-B-3 and 2-B-6,strong positive immunostaining was found in the reconstructed cartilage cultured with T-2 toxin,whereas no positive staining or very weak staining was observed in the cartilage cultured without T-2 toxin. Selenium could partly inhibit the effects of T-2 toxin above. Conclusion: T-2 toxin could inhibit aggrecan synthesis,promote aggrecanases and pro-inflammatory cytokines production,and consequently induce aggrecan degradation in chondrocytes. These will perturb metabolism balance between aggrecan synthesis and degradation in cartilage,inducing aggrecan loss in the end,which may be the initiation of the cartilage degradation.Si-yuan LI Jun-ling CAO Zhong-li SHI Jing-hong CHEN Zeng-tie ZHANG Clare E. HUGHES Bruce CATERSON 2008Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)2008,9,1:16
2Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues显示文摘AIM:To investigate the expression of chondroitin sulphate proteoglycans(CSPGs)in rat liver tissues of hepatocellular carcinoma(HCC).METHODS:Thirty male Sprague Dawley rats were randomly divided into two groups:control group(n=10) and HCC model group(n=20).Rats in the HCC model groups were intragastrically administrated with 0.2%(w/v)N-diethylnitrosamine(DEN)every 5 d for 16 wk,whereas 0.9%(w/v)normal saline was administered to rats in the control group.After 16 wk from the initiation of experiment,all rats were killed and livers were collected and fixed in 4%(w/v)paraformaldehyde.All tissues were embedded in paraffin and sectioned.Histological staining(hematoxylin and eosin and Toluidine blue)was performed to demonstrate the onset of HCC and the content of sulphated glycosaminoglycan(sGAG).Immunohistochemical staining was performed to investigate the expression of chondroitin sulphate(CS)/dermatan sulphate(DS)-GAG,heparan sulphate(HS)-GAG,keratan sulphate(KS)-GAG in liver tissues.Furthermore,expression and distribution of CSPG family members,including aggrecan,versican,biglycan and decorin in liver tissues,were also immunohistochemically determined.RESULTS:After 16 wk administration of DEN,malignant nodules were observed on the surface of livers from the HCC model group,and their hepatic lobule structures appeared largely disrupted under microscope.Toluidine blue staining demonstrated that there was an significant increase in sGAG content in HCC tissues when compared with that in the normal liver tissues from the control group[0.37±0.05 integrated optical density per stained area(IOD/area)and 0.21± 0.01 IOD/area,P<0.05].Immunohistochemical studies demonstrated that this increased sGAG in HCC tissues was induced by an elevated expression of CS/DS(0.28±0.02 IOD/area and 0.18±0.02 IOD/area,P< 0.05)and HS(0.30±0.03 IOD/area and 0.17±0.02 IOD/area,P<0.01)but not KS GAGs in HCC tissues.Further studies thereby were performed to investigate the expression and distribution of several CSPG components in HCC tissues,including aggrecan,versican,biglycan and decorin.Interestingly,there was a distinct distribution pattern for these CSPG components between HCC tissues and the normal tissues.Positive staining of aggrecan,biglycan and decorin was localized in hepatic membrane and/or pericellular matrix in normal liver tissues;however,their expression was mainly observed in the cytoplasm,cell membranes in hepatoma cells and/or pericellular matrix within HCC tissues.Semi-quantitative analysis indicated that there was a higher level of expression of aggrecan(0.43± 0.01 and 0.35±0.03,P<0.05),biglycan(0.32±0.01 and 0.25±0.01,P<0.001)and decorin(0.29±0.01 and 0.26±0.01,P<0.05)in HCC tissues compared with that in the normal liver tissues.Very weak versican positive staining was observed in hepatocytes near central vein in normal liver tissues;however there was an intensive versican distribution in fibrosis septa between the hepatoma nodules.Semi-quantitative analysis indicated that the positive rate of versican in hepatoma tissues from the HCC model group was much higher than that in the control group(33.61%and 21.28%,P <0.05).There was no positive staining in lumican and keratocan,two major KSPGs,in either normal or HCC liver tissues.CONCLUSION:CSPGs play important roles in the onset and progression of HCC,and may provide potential therapeutic targets and clinical biomarkers for this prevalent tumor in humans.Xiao-Li Jia Si-Yuan Li Shuang-Suo Dang Yan-An Cheng Xin Zhang Wen-Jun Wang Clare E Hughes Bruce Caterson 2012World Journal of Gastroenterology2012,18,30:2
3Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region显示文摘Rachel R. Huxley Federica Barzi Tai Hing Lam Sebastien Czernichow Xianghua Fang Tim Welborn Jonathan Shaw Hirotsugu Ueshima Paul Zimmet Sun Ha Jee Jeetesh V. Patel Ian Caterson Vlado Perkovic Mark Woodward 2011Circulation2011,,19:2
4Ischemia-reperfusion injury in vascularized composite allotransplantation显示文摘Caterson EJ Lopez J Medina M 2013J Craniofac Surg2013,24,:1
5Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects显示文摘James WP Caterson ID Coutinho W 2010N EngI J Med2010,363,10:1
6Associat- ion of serum leptin with hypoventilation in human obesity 显示文摘PHIPPS P R STARRITY E CATERSON I 2002Thorax2002,57,1:1
7Matrix metalloproteinases and aggrecanase:their role in disorders of the human intervertebral disc显示文摘Roberts S Caterson B Menage J 2000Spine2000,25,23:1
8Electrospun nanofi- brous structure a novel scaffold for tissue engineering显示文摘Li W J Laurencin CT Caterson 2002J Biomed Mater Res2002,60,:1
9Human inter- vertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro 显示文摘Johnson WE Caterson B Eisenstein SM 2005Spine2005,30,10:1
10Freeing the bain from the perineuronal net显示文摘Fox K Caterson B 2002Science2002,228,5596:1
11Matrix metalloproteinases and aggrecanase:their role in disorders of the human intervertebral disc显示文摘Roberts S Caterson B Menage J 2000Spine2000,25,23:1
12Electrospun nanofibers stmcture:A novel seaffold for tissue engineering显示文摘Li W J Laurencin C T Caterson E J 2002Journal of Biomedical Materials Research2002,60,4:1
13Matrix metalloproteinases and aggre canase:their role in disorders of the human intervertebral disc显示文摘Roberts S Caterson B Menage J 2000Spine2000,25,23:1
14Mechanical determinants of osteoarthrosis 显示文摘RADIN E L BURR D B CATERSON B 1991Semin Arthritis Rheum1991,21,32:1
15Clinical impact upon wound healing and inflammation in moist, wet, and dry environments显示文摘Junker JP Kamel RA Caterson E J 2013Adv Wound Care2013,2,7:1
16Eleetrospun nanofibrous structure: a novel scaffold for tissue engineering 显示文摘Li W J Laurencin C T Caterson E J 2002Journal of biomedical materials research2002,60,4:1
17Electrospun nanofibrous structure: a novel scaffold for tissue englneering显示文摘Li WJ Laurencin CT Caterson EJ 2002J Biomed Mater Res2002,60,4:1
18Matrix metallopro- teinases and aggrecanase: their role in disorders of the human intervertebral disc显示文摘Roberts S Caterson B Menage J 2000Spine~2000,25,23:1
19Human intervertebral disc aggrecan inhibits nerve growth in vitro显示文摘 Caterson B Eisenstein SM 2002Arthritis Rheum2002,46,10:1
20Matrix metalloproteinases and aggrencanase: their role in disorders or flumar intervertebral disc 显示文摘Roberts S Caterson B Menage J 2000Spine2000,25,:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费